10310sek
0,0 %
Date:2025-09-11Time:18:00:00Latest report:Q2-2025List:Mid CapTicker:BIOG B
Market Cap:10 430 msekEnterprise Value:9 807 msekNet Sales:1 440 msekEarnings:286,6 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:103,10
MA50:100,67
MA200:108,05
Price/MA200:-4,6 %
RSI (14):55,9
Price/MA50:2,4 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.